Kaiser Permanente Agrees to $556 Million Settlement Over Fraud Allegations

Kaiser Permanente has agreed to pay $556 million to settle allegations of Medicare fraud. The settlement resolves a lawsuit filed by the U.S. Department of Justice more than four years ago in San Francisco, which consolidated claims from six whistleblower complaints.

The lawsuit accused Kaiser affiliates, including the Kaiser Foundation Health Plan and various Permanente Medical Groups, of improperly influencing doctors to list inaccurate diagnoses on medical records. This practice aimed to secure higher reimbursements from the Medicare Advantage Plan, also known as Medicare Part C. Kaiser, based in Oakland, California, serves over 12 million members and operates numerous medical facilities across the United States.

Federal prosecutors contended that Kaiser pressured its physicians to amend medical records, often significantly after initial consultations with patients. More severe diagnoses generally lead to increased payments from Medicare, prompting these alleged alterations.

Assistant Attorney General Brett A. Shumate emphasized the importance of integrity within the Medicare Advantage program, stating, “More than half of our nation’s Medicare beneficiaries are enrolled in Medicare Advantage plans, and the government expects those who participate in the program to provide truthful and accurate information.”

Despite the substantial settlement, Kaiser maintains that there is no admission of wrongdoing or liability involved. The organization chose to settle to circumvent the potential delays, uncertainties, and costs associated with a trial. In a statement, Kaiser noted that “multiple major health plans have faced similar government scrutiny over Medicare Advantage risk adjustment standards and practices, reflecting industrywide challenges in applying these requirements.”

Kaiser also clarified that the case did not pertain to the quality of care provided to its members but rather focused on interpretations of documentation requirements within the Medicare risk adjustment program. This settlement represents a significant moment in ongoing discussions regarding compliance and ethical practices in the health care industry.